(Q37740954)

22 August 2017

1 reference

title

Classification and prognosis of invasive breast cancer: from morphology to molecular taxonomy (English)

1 reference

22 August 2017

1 reference

molecular phylogenetics

0 references

author name string

Stuart J Schnitt

series ordinal

1

1 reference

22 August 2017

publication date

1 May 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

23 Suppl 2

1 reference

22 August 2017

page(s)

S60-4

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.2010.33

22 August 2017

exact match

0 references

cites work

Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

Molecular classification and molecular forecasting of breast cancer: ready for clinical application?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

Supervised risk predictor of breast cancer based on intrinsic subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

Gene-expression signatures in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

The phenotypic spectrum of basal-like breast cancers: a critical appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

Triple negative breast carcinoma and the basal phenotype: from expression profiling to clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

Triple-negative breast cancer: risk factors to potential targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

Is 'basal-like' carcinoma of the breast a distinct clinicopathological entity? A critical review with cautionary notes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

BRCA1 dysfunction in sporadic basal-like breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

Basal-like breast cancer: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

Basal-like breast cancer and the BRCA1 phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

Epidemiology of basal-like breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

Basal-like breast carcinomas: clinical outcome and response to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

Demystifying basal-like breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

Patho-biological aspects of basal-like breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

Refinement of breast cancer classification by molecular characterization of histological special types

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

Understanding the molecular basis of histologic grade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

Commercialized multigene predictors of clinical outcome for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

Impact of basal-like breast carcinoma determination for a more specific therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

Basal cytokeratins in breast tumours among BRCA1, BRCA2 and mutation-negative breast cancer families

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

Relationship between clinical and pathologic features of ductal carcinoma in situ and patient age: an analysis of 657 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

Emerging biomarkers and new understanding of traditional markers in personalized therapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

Concordance among gene-expression-based predictors for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

Development of the 21-gene assay and its application in clinical practice and clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

Clinical application of the 70-gene profile: the MINDACT trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

The Nottingham prognostic index in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

7 January 2021

Expression profiling technology: its contribution to our understanding of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

7 January 2021

Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

7 January 2021

Basal cytokeratin and epidermal growth factor receptor expression are not predictive of BRCA1 mutation status in women with triple-negative breast cancers

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

7 January 2021

Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.33

7 January 2021

10.1038/MODPATHOL.2010.33

Identifiers

DOI

1 reference

22 August 2017

1 reference